Diabetes

SAN FRANCISCO — Health Mart on Tuesday officially unveiled its Health Mart brand, a new line of private-label, over-the-counter products that will help place the Health Mart banner in America's medicine cabinets.

The Health Mart private label will launch with diabetes products to coincide with National Diabetes Month.

BOSTON — Employee wellness experts from Babcock & Wilcox, Caesars Entertainment and others spoke to the synergies that such a company as Walgreens' Take Care Health Systems can create across their health management strategies during a panel discussion here last week at the National Conference on Health, Productivity and Human Capital hosted by the National Business Group on Health.

Representing businesses that collectively employ more than 120,000 workers, the panelists discussed a number of emerging themes in employer-sponsored health care, including:

TITUSVILLE, N.J. — A Johnson & Johnson subsidiary has sent a regulatory application to the Food and Drug Administration seeking approval for one of its drugs in treating diabetes-related pain.

DEERFIELD, Ill. — Select Walgreens across the country will offer free blood-glucose testing during National Diabetes Month this November, Walgreens announced Monday.

ORLANDO, Fla. — This year’s fourth annual Retail Clinician Education Congress kicked off on Monday, bringing together hundreds of retail healthcare professionals to network, receive exclusive accreditation and honor those providers and key executive leaders whose work throughout the year has distinguished them among their peers in retail health care.

WASHINGTON — New guidelines that will ensure women receive preventive health services at no additional cost were announced Monday by the Department of Health and Human Services.

Developed by the independent Institute of Medicine, the new guidelines require new health insurance plans to cover women’s preventive services, such as well-woman visits, breast-feeding support, domestic violence screening and contraception without charging a co-payment, co-insurance or a deductible.

NEW DELHI — Eli Lilly’s India division and Indian generic drug maker Lupin will distribute Lilly’s insulin products in India and Nepal under an agreement between the two companies announced Friday.

Under the collaboration, Lilly and Lupin will promote and distribute Huminsulin R, Huminsulin NPH, Huminsulin 50/50, Huminsulin 30/70 and Humapen Ergo II. The companies said the deal would double the current customer base.

BANGALORE, India — The Food and Drug Administration has approved a generic drug for diabetes made by Indian generic drug maker Strides Arcolab.

The FDA approved acarbose tablets in the 25-mg, 50-mg and 100-mg strengths. The drug is a niche drug used to treat Type 2 diabetes, Strides said.

Acarbose tablets have sales of about $21 million, according to IMS Health.